105 related articles for article (PubMed ID: 30208014)
1. The Role of miR-15a and miR-16-1 in the Pathogenesis of Chronic Lymphocytic Leukemia, and the Importance of microRNAs in Targeted Therapies.
Calva-Lopez A; Tirado CA
J Assoc Genet Technol; 2018; 44(3):84-87. PubMed ID: 30208014
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
3. 13q14 deletions in CLL involve cooperating tumor suppressors.
Palamarchuk A; Efanov A; Nazaryan N; Santanam U; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
Blood; 2010 May; 115(19):3916-22. PubMed ID: 20071661
[TBL] [Abstract][Full Text] [Related]
4. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
[TBL] [Abstract][Full Text] [Related]
5. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
[TBL] [Abstract][Full Text] [Related]
6. Role of miR-15/16 in CLL.
Pekarsky Y; Croce CM
Cell Death Differ; 2015 Jan; 22(1):6-11. PubMed ID: 24971479
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
[TBL] [Abstract][Full Text] [Related]
8. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
Hanlon K; Rudin CE; Harries LW
PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis.
Javandoost E; Firoozi-Majd E; Rostamian H; Khakpoor-Koosheh M; Mirzaei HR
Curr Med Chem; 2020; 27(2):282-297. PubMed ID: 31544709
[TBL] [Abstract][Full Text] [Related]
10.
Rassenti LZ; Balatti V; Ghia EM; Palamarchuk A; Tomasello L; Fadda P; Pekarsky Y; Widhopf GF; Kipps TJ; Croce CM
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10731-10736. PubMed ID: 28923920
[TBL] [Abstract][Full Text] [Related]
11. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
[TBL] [Abstract][Full Text] [Related]
12. Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia.
Farahat NMG; Elkaffash DMNED; Alghandour AH; Swelem RS; Abo El-Wafa RAH
Indian J Hematol Blood Transfus; 2019 Jan; 35(1):89-99. PubMed ID: 30828154
[TBL] [Abstract][Full Text] [Related]
13. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNA genes in cancer pathogenesis.
Pekarsky Y; Croce CM
Adv Biol Regul; 2019 Jan; 71():219-223. PubMed ID: 30611710
[TBL] [Abstract][Full Text] [Related]
15. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.
Srivastava S; Tsongalis GJ; Kaur P
Clin Biochem; 2016 Nov; 49(16-17):1307-1310. PubMed ID: 27544753
[TBL] [Abstract][Full Text] [Related]
17. Novel insights in molecular mechanisms of CLL.
Zanesi N; Balatti V; Bottoni A; Croce CM; Pekarsky Y
Curr Pharm Des; 2012; 18(23):3363-72. PubMed ID: 22591386
[TBL] [Abstract][Full Text] [Related]
18. 13q14 Deletion and Its Effect on Prognosis of Chronic Lymphocytic Leukemia.
Khalid K; Padda J; Syam M; Moosa A; Kakani V; Sanka S; Zubair U; Padda S; Cooper AC; Jean-Charles G
Cureus; 2021 Aug; 13(8):e16839. PubMed ID: 34522485
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
20. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]